3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one
TL;DR: 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one (CAS 878985-14-9) is a chemical compound with molecular formula C23H26N2O4 and molecular weight 394.19 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)indol-2-one
Also Known As: 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one, 3-hydroxy-3-(2-(4-methoxyphenyl)-2-oxoethyl)-1-(piperidin-1-ylmethyl)indolin-2-one, 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxo-ethyl]-1-(1-piperidylmethyl)indol-2-one, 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)indol-2-one
| Molecular Formula | C23H26N2O4 |
|---|---|
| Molecular Weight | 394.19 g/mol |
| LogP | 2.9458 |
| Topological Polar Surface Area | 70.08 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Exact Mass | 394.18927 |
| Heavy Atoms | 29 |
| Complexity | 905.34875 |
Chemical Identifiers
| CAS Number | 878985-14-9 |
|---|---|
| SMILES | COC1=CC=C(C=C1)C(=O)CC2(C3=CC=CC=C3N(C2=O)CN4CCCCC4)O |
Product Overview
3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one (CAS 878985-14-9), with molecular formula C23H26N2O4 and molecular weight 394.19 g/mol. IUPAC: 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)indol-2-one.
Chemical Property Profile of 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one
Property Insights of 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one
The XLogP value of 2.9458 suggests moderate lipophilicity, balancing water solubility and membrane permeability for 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one. The TPSA of 70.08 Ų falls within the moderate polarity range, balancing permeability and solubility for 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one. Following Lipinski's Rule of Five, 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one has 1 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one?
The CAS number of 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one is 878985-14-9.
What is the molecular formula of 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one?
The molecular formula of 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one is C23H26N2O4.
What is the molecular weight of 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one?
The molecular weight of 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one is 394.19 g/mol.
Where can I buy 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one?
You can request a quote for 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one?
Yes, KEHONG BIO provides custom synthesis services for 3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1-(piperidin-1-ylmethyl)-1,3-dihydro-2H-indol-2-one and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.